<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Respiratory System Drugs - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#cough">Drugs for Cough</a></li>
            <li><a href="#expectorants">Expectorants & Mucolytics</a></li>
            <li><a href="#antitussives">Antitussives</a></li>
            <li><a href="#asthma">Bronchial Asthma Overview</a></li>
            <li><a href="#bronchodilators">Bronchodilators</a></li>
            <li><a href="#methylxanthines">Methylxanthines (Theophylline)</a></li>
            <li><a href="#anticholinergics">Anticholinergics</a></li>
            <li><a href="#corticosteroids">Corticosteroids</a></li>
            <li><a href="#leukotriene">Leukotriene Antagonists</a></li>
            <li><a href="#management">Management Guidelines</a></li>
            <li><a href="#status-asthmaticus">Status Asthmaticus</a></li>
            <li><a href="#case-study">Case Studies</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>ü´Å</span>
                        <span>Topic 17</span>
                    </div>
                    <h1 class="document-title">Drugs for Cough and Bronchial Asthma</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Respiratory System Drugs</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>55 min read</span>
                        </div>
                    </div>
                </header>
                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Cough Intro -->
                    <section class="content-section" id="cough">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üó£Ô∏è</span>
                                Drugs for Cough
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Cough is a protective reflex, its purpose being expulsion of respiratory secretions and
                                foreign particles from air passages. It occurs due to stimulation of mechano- or
                                chemoreceptors in throat and respiratory passages or stretch receptors in the lungs.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Types of Cough</h4>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><strong>Useful (Productive) Cough:</strong> Serves to
                                            drain the airway; suppression is not desirable unless the amount of
                                            expectoration is small compared to the effort.</li>
                                        <li class="list-item"><strong>Useless (Nonproductive) Cough:</strong> Should be
                                            suppressed.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Expectorants -->
                    <section class="content-section" id="expectorants">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß™</span>
                                Expectorants & Mucolytics
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Demulcents and Expectorants</h3>
                            <p><strong>Pharyngeal demulcents</strong> soothe the throat and reduce afferent impulses
                                from inflamed mucosa. <strong>Expectorants (Mucokinetics)</strong> increase bronchial
                                secretion or reduce viscosity.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Guaiphenesin:</strong> Plant product; enhances secretion
                                    and mucociliary function. The only expectorant approved by US-FDA.</li>
                                <li class="list-item"><strong>Sodium/Potassium citrate:</strong> Increase secretion by
                                    salt action.</li>
                                <li class="list-item"><strong>Ammonium salts:</strong> Nauseating reflex increases
                                    respiratory secretions.</li>
                            </ul>

                            <h3>Mucolytics</h3>
                            <p>Agents that liquefy tenacious sputum.</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Mechanism & Features</th>
                                            <th>Uses</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Bromhexine</strong></td>
                                            <td>Derivative of alkaloid vasicine. Depolymerises mucopolysaccharides,
                                                liberating lysosomal enzymes.</td>
                                            <td>Productive cough.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Ambroxol</strong></td>
                                            <td>Metabolite of bromhexine with similar action.</td>
                                            <td>Productive cough.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Acetylcysteine</strong></td>
                                            <td>Opens disulfide bonds in mucoproteins. Can be given orally or by
                                                inhalation.</td>
                                            <td>Viscid sputum, Paracetamol poisoning (antidote).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Carbocisteine</strong></td>
                                            <td>Liquefies sputum. May break gastric mucus barrier (avoid in peptic
                                                ulcer).</td>
                                            <td>Chronic bronchitis.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Antitussives -->
                    <section class="content-section" id="antitussives">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõë</span>
                                Antitussives
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Drugs that act in the CNS to raise the threshold of cough centre or peripherally to
                                reduce tussal impulses. Used for dry nonproductive cough.</p>

                            <h3>Opioid Antitussives</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Codeine:</strong> Standard antitussive; more selective for
                                    cough center than morphine. Abuse liability low but present. Constipation is a
                                    drawback.</li>
                                <li class="list-item"><strong>Pholcodine:</strong> No analgesic/addicting property.
                                    Longer acting (12 hr).</li>
                            </ul>

                            <h3>Nonopioid Antitussives</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Noscapine:</strong> Opium alkaloid (benzoisoquinoline
                                    series). No narcotic/analgesic effects. Equipotent to codeine. Releases histamine
                                    (bronchoconstriction in asthmatics).</li>
                                <li class="list-item"><strong>Dextromethorphan:</strong> Synthetic central NMDA
                                    antagonist. $d$-isomer is antitussive, $l$-isomer is analgesic. Nonaddicting.</li>
                                <li class="list-item"><strong>Chlophedianol:</strong> Central antitussive with weak
                                    antihistaminic/anticholinergic actions.</li>
                            </ul>

                            <h3>Antihistamines</h3>
                            <p><strong>Chlorpheniramine, Diphenhydramine, Promethazine:</strong> Added to formulations
                                for sedative/anticholinergic action. No selective antitussive action.</p>
                        </div>
                    </section>

                    <!-- Section 4: Asthma Overview -->
                    <section class="content-section" id="asthma">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üå¨Ô∏è</span>
                                Bronchial Asthma: Overview
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Asthma is primarily an inflammatory condition characterized by hyperresponsiveness of
                                tracheobronchial smooth muscle. Inflammation is initiated by mast cells and dominated by
                                eosinophils, lymphocytes, and mast cells.</p>
                            <p><strong>Mediators:</strong> Histamine, Protease enzymes, TNF $\alpha$, PGs, Leukotrienes
                                (LTs), PAF, Interleukins.</p>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">COPD vs Asthma</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>COPD</strong> is also inflammatory (neutrophils/macrophages) but
                                        characterized by progressive emphysema and bronchiolar fibrosis. Airflow
                                        limitation is largely irreversible. Smoking is a major cause.</p>
                                </div>
                            </div>

                            <h3>Approaches to Treatment</h3>
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>Bronchodilators:</strong> Sympathomimetics,
                                    Methylxanthines, Anticholinergics.</li>
                                <li class="list-item"><strong>Anti-inflammatory:</strong> Corticosteroids, Mast cell
                                    stabilizers, Leukotriene antagonists, Anti-IgE antibody.</li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 5: Bronchodilators -->
                    <section class="content-section" id="bronchodilators">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üöÄ</span>
                                Sympathomimetic Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Adrenergic drugs cause bronchodilatation through $\beta_2$ receptor stimulation
                                $\rightarrow$ increased cAMP $\rightarrow$ relaxation.</p>

                            <h3>Selective $\beta_2$ Agonists</h3>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Short Acting (SABA)</h4>
                                    <p><strong>Salbutamol (Albuterol), Terbutaline.</strong></p>
                                    <ul>
                                        <li>Inhaled onset: 5 min.</li>
                                        <li>Duration: 2-4 hours.</li>
                                        <li>Use: Abort/terminate attacks (Rescue).</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Long Acting (LABA)</h4>
                                    <p><strong>Salmeterol, Formoterol.</strong></p>
                                    <ul>
                                        <li>Duration: >12 hours.</li>
                                        <li>Use: Maintenance therapy, nocturnal asthma.</li>
                                        <li><strong>Caution:</strong> Should be used with inhaled steroids.</li>
                                    </ul>
                                </div>
                            </div>

                            <p><strong>Adverse Effects:</strong> Muscle tremors (dose related), palpitation,
                                restlessness, nervousness, hypokalaemia.</p>
                            <p><strong>Bambuterol:</strong> Prodrug of terbutaline. Long acting (24 hr). Suitable for
                                nocturnal asthma.</p>
                        </div>
                    </section>

                    <!-- Section 6: Methylxanthines -->
                    <section class="content-section" id="methylxanthines">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚òï</span>
                                Methylxanthines (Theophylline)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Theophylline</strong>, Caffeine, and Theobromine are naturally occurring
                                alkaloids.</p>

                            <h3>Mechanism of Action</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Inhibition of Phosphodiesterase (PDE):</strong> Increases
                                    cyclic nucleotides (cAMP/cGMP) $\rightarrow$ bronchodilatation, cardiac stimulation.
                                </li>
                                <li class="list-item"><strong>Blockade of Adenosine Receptors:</strong> Adenosine causes
                                    bronchoconstriction and CNS depression; theophylline antagonizes this.</li>
                                <li class="list-item"><strong>Release of $Ca^{2+}$:</strong> From sarcoplasmic reticulum
                                    (high doses).</li>
                                <li class="list-item"><strong>Histone Deacetylation:</strong> Enhancement at low doses
                                    suppresses inflammatory gene transcription.</li>
                            </ul>

                            <h3>Pharmacological Actions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>CNS:</strong> Stimulation, alertness (Caffeine >
                                    Theophylline). High doses: convulsions.</li>
                                <li class="list-item"><strong>CVS:</strong> Cardiac stimulation (rate/force),
                                    vasodilatation (systemic), vasoconstriction (cranial - Caffeine).</li>
                                <li class="list-item"><strong>Smooth Muscle:</strong> Relaxation (Bronchi: Theophylline
                                    > Caffeine).</li>
                                <li class="list-item"><strong>Kidney:</strong> Mild diuresis.</li>
                            </ul>

                            <h3>Pharmacokinetics</h3>
                            <p>Narrow margin of safety. Metabolized by CYP1A2. Zero order kinetics at higher doses.</p>
                            <ul>
                                <li><strong>Plasma $t_{1/2}$:</strong> Adults 7-12 hr; Children 3-5 hr.</li>
                                <li><strong>Interactions:</strong> Smoking, Phenytoin, Rifampicin <em>increase</em>
                                    clearance (dose increase needed). Erythromycin, Ciprofloxacin, Cimetidine
                                    <em>decrease</em> clearance (toxicity risk).</li>
                            </ul>

                            <h3>Adverse Effects</h3>
                            <p>Headache, nervousness, nausea (early). Arrhythmias, seizures (severe).</p>
                        </div>
                    </section>

                    <!-- Section 7: Anticholinergics -->
                    <section class="content-section" id="anticholinergics">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üåµ</span>
                                Anticholinergics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Block $M_3$ receptor mediated cholinergic constrictor tone. Act primarily in larger
                                airways.</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Duration</th>
                                            <th>Key Use</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Ipratropium bromide</strong></td>
                                            <td>Short (4-6 hr)</td>
                                            <td>COPD, Asthma (adjuvant)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Tiotropium bromide</strong></td>
                                            <td>Long (24 hr)</td>
                                            <td>COPD maintenance</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p><strong>Note:</strong> Inhaled anticholinergics are the <strong>bronchodilators of choice
                                    in COPD</strong>.</p>
                        </div>
                    </section>

                    <!-- Section 8: Corticosteroids -->
                    <section class="content-section" id="corticosteroids">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìâ</span>
                                Corticosteroids
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Not bronchodilators, but suppress inflammation, reduce bronchial hyperreactivity, and
                                mucosal edema. Most effective for long-term control.</p>

                            <h3>Systemic Corticosteroids</h3>
                            <p><strong>Use:</strong> Severe chronic asthma, Status asthmaticus (IV Hydrocortisone).</p>

                            <h3>Inhaled Corticosteroids (ICS)</h3>
                            <p>High topical, low systemic activity.</p>
                            <ul>
                                <li><strong>Drugs:</strong> Beclomethasone, Budesonide, Fluticasone, Ciclesonide
                                    (prodrug, activated in lung).</li>
                                <li><strong>Use:</strong> Persistent asthma. Not for acute attack.</li>
                                <li><strong>Adverse Effects:</strong> Oropharyngeal candidiasis, hoarseness (minimize by
                                    spacer/gargling). Systemic effects rare at low doses.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 9: Leukotriene Antagonists -->
                    <section class="content-section" id="leukotriene">
                        <div class="section-header">
                            <div class="section-number">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõ°Ô∏è</span>
                                Leukotriene Antagonists
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Montelukast</strong> and <strong>Zafirlukast</strong>.</p>
                            <p>Competitively antagonize $cysLT_1$ receptors (mediators of bronchoconstriction/mucus).
                                Effective in aspirin-induced asthma and exercise-induced asthma. Oral administration.
                                Very safe.</p>

                            <h3>Mast Cell Stabilizers</h3>
                            <p><strong>Sodium Cromoglycate:</strong> Inhibits degranulation of mast cells. Prophylactic
                                use only. Not a bronchodilator.</p>

                            <h3>Anti-IgE Antibody</h3>
                            <p><strong>Omalizumab:</strong> Humanized monoclonal antibody against IgE. Neutralizes free
                                IgE. Used in severe extrinsic asthma.</p>
                        </div>
                    </section>

                    <!-- Section 10: Management -->
                    <section class="content-section" id="management">
                        <div class="section-header">
                            <div class="section-number">10</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìã</span>
                                Management Guidelines (Stepwise)
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Step 1 (Mild Episodic):</strong> Inhaled short-acting
                                    $\beta_2$ agonist (SABA) as needed.</li>
                                <li class="list-item"><strong>Step 2 (Mild Persistent):</strong> Regular low-dose ICS +
                                    SABA for episodes.</li>
                                <li class="list-item"><strong>Step 3 (Moderate):</strong> Low dose ICS + Long-acting
                                    $\beta_2$ agonist (LABA).</li>
                                <li class="list-item"><strong>Step 4 (Severe):</strong> High dose ICS + LABA +
                                    (Leukotriene antagonist/Theophylline).</li>
                                <li class="list-item"><strong>Step 5:</strong> Add oral steroids.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 11: Status Asthmaticus -->
                    <section class="content-section" id="status-asthmaticus">
                        <div class="section-header">
                            <div class="section-number">11</div>
                            <h2 class="section-title">
                                <span class="title-icon">üö®</span>
                                Status Asthmaticus
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Acute severe asthma; life-threatening. Treatment:</p>
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>Hydrocortisone hemisuccinate:</strong> 100 mg i.v. stat,
                                    then infusion.</li>
                                <li class="list-item"><strong>Nebulized Salbutamol + Ipratropium:</strong> Driven by
                                    $O_2$.</li>
                                <li class="list-item"><strong>High flow Oxygen.</strong></li>
                                <li class="list-item"><strong>Salbutamol/Terbutaline:</strong> i.m./s.c. if inhalation
                                    not effective.</li>
                                <li class="list-item"><strong>Intubation/Ventilation:</strong> If needed.</li>
                                <li class="list-item"><strong>Antibiotics/Hydration.</strong></li>
                            </ol>
                            <p><em>Note: IV Aminophylline is outmoded.</em></p>
                        </div>
                    </section>

                    <!-- Section 12: Case Studies -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">12</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 16.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>30-year-old man with daily breathlessness, using salbutamol inhaler frequently.
                                        Spirometry shows moderate asthma.</p>
                                    <p><strong>(a) Treatment adequacy:</strong> Not adequate. Frequent use of SABA
                                        indicates lack of control. <strong>First line treatment: Inhaled Corticosteroid
                                            (ICS)</strong> like Beclomethasone or Budesonide should be started
                                        regularly.</p>
                                    <p><strong>(b) Salbutamol use:</strong> Yes, continue SABA <em>only</em> for
                                        symptomatic relief of acute wheezing episodes (rescue).</p>
                                    <p><strong>(c) Alternatives:</strong> If not willing for inhaler, oral
                                        <strong>Montelukast</strong> or <strong>Theophylline</strong> (SR) can be tried,
                                        but are less effective than ICS.</p>
                                </div>
                            </div>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 16.2</h4>
                                </div>
                                <div class="callout-content">
                                    <p>60-year-old COPD patient on Ipratropium + Theophylline. Developed fever, took
                                        Erythromycin. Presented with epigastric pain, restlessness, palpitation, tremor,
                                        vomiting.</p>
                                    <p><strong>(a) Reason for illness:</strong> <strong>Theophylline Toxicity</strong>.
                                        Erythromycin inhibits CYP1A2, the enzyme that metabolizes theophylline, leading
                                        to increased plasma levels of theophylline.</p>
                                    <p><strong>(b) Prevention:</strong> Avoid Erythromycin. Use an antibiotic that does
                                        not interact (e.g., Azithromycin, Amoxicillin). Or reduce Theophylline dose.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-16-rheumatoid-gout.html"
                            class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Antirheumatoid & Antigout</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>17</span>
                                <span class="progress-separator">/</span>
                                <span>20</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 85%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-18-pituitary.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Anterior Pituitary Hormones</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>